Health Catalyst Inc
NASDAQ:HCAT

Watchlist Manager
Health Catalyst Inc Logo
Health Catalyst Inc
NASDAQ:HCAT
Watchlist
Price: 4.1 USD 3.02% Market Closed
Market Cap: 287.9m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+5%
Revenue
Forecast
+6%
Operating Income
Forecast
+8%
Net Income
Forecast
+5%

Wall Street
Price Targets

HCAT Price Targets Summary
Health Catalyst Inc

Wall Street analysts forecast HCAT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HCAT is 8.16 USD with a low forecast of 4.04 USD and a high forecast of 16.8 USD.

HCAT Lowest Forecast
Wall Street Target
4.04 USD
1% Downside
HCAT Average Forecast
Wall Street Target
8.16 USD
99% Upside
HCAT Highest Forecast
Wall Street Target
16.8 USD
310% Upside
Lowest
Price Target
4.04 USD
1% Downside
Average
Price Target
8.16 USD
99% Upside
Highest
Price Target
16.8 USD
310% Upside
Health Catalyst Inc Competitors:
Price Targets
CONTX
ContextVision AB
17% Upside
300451
B-SOFT Co Ltd
14% Upside
CGS
CogState Ltd
14% Upside
OMCL
Omnicell Inc
75% Upside
CONTX
ContextVision AB
17% Upside
300451
B-SOFT Co Ltd
14% Upside
CGS
CogState Ltd
14% Upside
OMCL
Omnicell Inc
75% Upside
M7T
Mach7 Technologies Ltd
266% Upside
PHR
Phreesia Inc
33% Upside
INSP
Inspire Medical Systems Inc
45% Upside
NUTX
Nutex Health Inc
41% Downside

Revenue
Forecast

Revenue Estimate
Health Catalyst Inc

For the last 6 years the compound annual growth rate for Health Catalyst Inc's revenue is 18%. The projected CAGR for the next 3 years is 10%.

18%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Health Catalyst Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
55%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Health Catalyst Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
HCAT intrinsic value, competitors valuation, and company profile.
DCF Valuation
HCAT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HCAT stock valuation using valuation multiples.
Wall Street Estimates
HCAT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HCAT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HCAT's stock price target?
Price Target
8.16 USD

According to Wall Street analysts, the average 1-year price target for HCAT is 8.16 USD with a low forecast of 4.04 USD and a high forecast of 16.8 USD.

What is Health Catalyst Inc's Revenue forecast?
Projected CAGR
10%

For the last 6 years the compound annual growth rate for Health Catalyst Inc's revenue is 18%. The projected CAGR for the next 3 years is 10%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 250,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.